Results 201 to 210 of about 170,520 (332)

Distribution of Ophthalmology Grant Opportunities and Variation Amongst Subspecialties in Australia

open access: yes
Clinical &Experimental Ophthalmology, EarlyView.
Benjamin Cook   +3 more
wiley   +1 more source

Evaluating the outcomes of pluripotent stem‐cell‐derived photoreceptor transplantation in retinal repair

open access: yesThe FEBS Journal, EarlyView.
Transplantation of stem cell‐derived photoreceptors in retinal repair. We summarize methods for differentiating stem cells and describe surgical techniques for transplanting photoreceptor precursors to restore visual function (A). The effectiveness of these techniques is assessed with behavioral (B) and in vitro assays (C) using mouse models that mimic
Darin Zerti   +5 more
wiley   +1 more source

Transferrin is a drug candidate for the treatment of dry age-related macular degeneration (AMD). [PDF]

open access: yesCell Death Dis
Youale J   +12 more
europepmc   +1 more source

Illumination and reading performance in age‐related macular degeneration [PDF]

open access: bronze, 2001
Alex R. Bowers   +2 more
openalex   +1 more source

Bilateral MacUlar Degeneration [PDF]

open access: yesProceedings of the Royal Society of Medicine, 1928
openaire   +3 more sources

A Realist Evaluation of the Implementation and Use of Patient‐Reported Outcomes in Four Value‐Based Healthcare Programmes

open access: yesJournal of Advanced Nursing, EarlyView.
ABSTRACT Aim To investigate what works when using Patient‐Reported Outcome Measures (PROMs), for whom, in what contexts, and why in four Value‐Based Healthcare (VBHC) programmes. Design Realist evaluation. Methods Evaluation of Heart Failure, Parkinson's Disease, Epilepsy and Cataract surgery programmes using data from a scoping review, documentary ...
Mayara S. Bianchim   +6 more
wiley   +1 more source

Multiply scattered light tomography and confocal imaging: detecting neovascularization in age-related macular degeneration

open access: gold, 2000
A. E. Elsner   +11 more
openalex   +1 more source

Home - About - Disclaimer - Privacy